已收盘 02-22 16:00:00 美东时间
0.000
0.00%
EntityCheck has reviewed over 700 bankrupt companies and conducted a study of h...
03-25 01:37
Sensei Biotherapeutics will implement a 1-for-20 reverse stock split on June 16, 2025, to meet Nasdaq's listing requirements. The split will reduce the number of outstanding shares from 25.2 million to 1.3 million, affecting all stockholders and adjusting equity plans proportionally.
2025-06-13 11:30